These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 15756005

  • 1. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Kuo MC, Tang TC.
    Clin Cancer Res; 2005 Mar 01; 11(5):1821-6. PubMed ID: 15756005
    [Abstract] [Full Text] [Related]

  • 2. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
    Shih LY, Lin TL, Wang PN, Wu JH, Dunn P, Kuo MC, Huang CF.
    Cancer; 2004 Sep 01; 101(5):989-98. PubMed ID: 15329908
    [Abstract] [Full Text] [Related]

  • 3. AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples.
    Shih LY, Liang DC, Huang CF, Wu JH, Lin TL, Wang PN, Dunn P, Kuo MC, Tang TC.
    Leukemia; 2006 Apr 01; 20(4):604-9. PubMed ID: 16453003
    [Abstract] [Full Text] [Related]

  • 4. CEBPalpha mutations in childhood acute myeloid leukemia.
    Liang DC, Shih LY, Huang CF, Hung IJ, Yang CP, Liu HC, Jaing TH, Wang LY, Chang WH.
    Leukemia; 2005 Mar 01; 19(3):410-4. PubMed ID: 15618961
    [Abstract] [Full Text] [Related]

  • 5. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY, Huang CF, Wang PN, Wu JH, Lin TL, Dunn P, Kuo MC.
    Leukemia; 2004 Mar 01; 18(3):466-75. PubMed ID: 14737077
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST, Bu X, Thein M, Lee M, Brynes RK.
    Am J Hematol; 2003 May 01; 73(1):12-7. PubMed ID: 12701114
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
    Pinheiro RF, de Sá Moreira E, Silva MR, Alberto FL, Chauffaille Mde L.
    Cancer Genet Cytogenet; 2008 Jun 01; 183(2):89-93. PubMed ID: 18503825
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M, Mirro J, Kitchingman G, McCormick F, Mertelsmann R, Herrmann F, Koeffler HP.
    Oncogene; 1992 Feb 01; 7(2):263-8. PubMed ID: 1549347
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
    Wulfert M, Küpper AC, Tapprich C, Bottomley SS, Bowen D, Germing U, Haas R, Gattermann N.
    Exp Hematol; 2008 May 01; 36(5):577-86. PubMed ID: 18439489
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A, Luthra R, Medeiros LJ, Zuo Z.
    Am J Clin Pathol; 2011 Jan 01; 135(1):62-9. PubMed ID: 21173125
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y, Harada H.
    J Cell Physiol; 2009 Jul 01; 220(1):16-20. PubMed ID: 19334039
    [Abstract] [Full Text] [Related]

  • 20. [Detection of point mutation at second tyrosine kinase domain of FLT3 gene in acute myeloid leukemia].
    Wang LH, Wang M, Zhou CL, Chen S, Zhang XW, Xing HY, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun 01; 26(6):335-8. PubMed ID: 16185475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.